Ghana vs Madagascar: Population requiring preventive chemotherapy for schistosomiasis
Ghana
8.31 million
in 2024
Madagascar
13.03 million
in 2024
Ghana rank
9th
Madagascar rank
6th
Population requiring preventive chemotherapy for schistosomiasis over time
- Ghana
- Madagascar
How they compare
Madagascar currently reports 13.03 million against 8.31 million in Ghana, a difference of 4.73 million.
That makes Madagascar's figure about 1.6 times Ghana's.
The two have swapped places 3 times across 15 shared years of data; in 2010 it was Ghana ahead.
Ghana ranks 9th and Madagascar ranks 6th of 52 countries.
Across the 2 decades both report, Ghana averaged higher in 1 and Madagascar in 1.
Head to head by decade
| Decade | Ghana | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.62 million | 7.86 million | 759,878 | Ghana |
| 2020s | 10.10 million | 11.30 million | 1.20 million | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Ghana or Madagascar?
- Madagascar, at 13.03 million against 8.31 million in Ghana as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Ghana and Madagascar?
- 4.73 million, with Madagascar ahead.
- How many years of comparable data are there for Ghana and Madagascar?
- 15 years are reported by both, from 2010 to 2024.
- How do Ghana and Madagascar rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Ghana ranks 9th and Madagascar ranks 6th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.